Insider trading · Q3 2026 · CIK 1829802

Faeth Therapeutics, Inc. (FTH) insider trading.

In Q3 2026, insiders at Faeth Therapeutics, Inc. reported 6 non-derivative transactions on 6 Forms 3, 4 and 5: 6 open-market purchases worth $326K and 0 sales.

Transactions
6
Purchases (P)
6
Sales (S)
0
Net shares, P minus S
13,634
Insiders
1
Last filed
2026-07-01

Insiders

InsiderRelationshipTransactionsBuysSales
Stephenson Brian COfficer · Chief Financial Officer660

Transactions

6 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-07-01Stephenson Brian CP (A)600$24.2246,688Form 4
2026-07-01Stephenson Brian CP (A)4,400$23.446,088Form 4
2026-06-30Stephenson Brian CP (A)1,638$23.8837,433Form 4
2026-06-30Stephenson Brian CP (A)1,910$22.9535,795Form 4
2026-06-30Stephenson Brian CP (A)4,255$24.9841,688Form 4
2026-06-29Stephenson Brian CP (A)831$23.3433,885Form 4

Transaction codes in this quarter

Get FTH insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1829802&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · FTH company page · Faeth Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Faeth Therapeutics, Inc. (FTH)?

In Q3 2026, insiders at Faeth Therapeutics, Inc. reported 6 non-derivative transactions on 6 Forms 3, 4 and 5: 6 open-market purchases worth $326K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Faeth Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/fth.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.